The big question
Scalp cooling, sometimes called a cold cap, chills the scalp during chemotherapy to help prevent hair loss. At the authors' cancer center, non-White patients with breast cancer were about six times less likely than White patients to use it. This study asked why.
What they did
Researchers held one-hour video interviews with 17 Black women with breast cancer who received chemotherapy. They talked about how hair loss affected them, how they felt about scalp cooling, and what would help. The team then sorted the conversations into common themes.
What they found
Women described key barriers: few Black women shown in scalp-cooling advertising, worries that it would not work on textured hair, and cost, which came up often. Ten of the 17 women did not use scalp cooling. Fifteen of the 17 (88.2%) had not heard of minoxidil, a medicine used to treat hair loss. Women suggested better counseling on using scalp cooling with textured hair, access to wigs and other ways to cover hair loss, financial help, and earlier referral to a skin and hair doctor (dermatologist).
Why it matters
Hair loss is deeply personal and tied to identity. Knowing these barriers can help care teams offer every patient real choices.
What it doesn't mean
This was a small study at one center, and people chose to take part. It describes experiences; it did not test how well scalp cooling works on different hair types.
Read the original abstract
Abstract reproduced from Minta A et al., Supportive Care in Cancer (2026), under a CC BY 4.0 license. Plain-English summary by Womanhattan.
This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.